APA (7th ed.) Citation

RT, K., A, B., E, F., VD, P., S, G., DA, P., . . . PJ, H. (2020). Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium. Pediatric blood & cancer, 67(7), e28284. https://doi.org/10.1002/pbc.28284

Chicago Style (17th ed.) Citation

RT, Kurmasheva, et al. "Evaluation of VTP-50469, a Menin-MLL1 Inhibitor, Against Ewing Sarcoma Xenograft Models by the Pediatric Preclinical Testing Consortium." Pediatric Blood & Cancer 67, no. 7 (2020): e28284. https://doi.org/10.1002/pbc.28284.

MLA (9th ed.) Citation

RT, Kurmasheva, et al. "Evaluation of VTP-50469, a Menin-MLL1 Inhibitor, Against Ewing Sarcoma Xenograft Models by the Pediatric Preclinical Testing Consortium." Pediatric Blood & Cancer, vol. 67, no. 7, 2020, p. e28284, https://doi.org/10.1002/pbc.28284.